AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
BioHarvest Sciences has completed a public offering of 2.85 million shares at $7 per share, raising $19.9 million. The company plans to use the proceeds for manufacturing expansion, R&D, marketing, debt reduction, and general corporate purposes. CEO Ilan Sobel stated that the funding will allow for accelerated growth across both product and CDMO services businesses. The company will provide updates on strategic initiatives during its third-quarter earnings call on November 13.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet